JOSIR Side Effects

6258840-2 | Acute Febrile Neutrophilic Dermatosis, Eosinophilia, Leukocytoclastic Vasculitis, Leukocytosis, Purpura, Pyrexia, Rash Erythematous, Rash Maculo-papular
on Jun 29, 2009 Male patient from , 80 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Josir (View Usage). Patient experienced the following unwanted or unexpected effects: acute febrile neutrophilic dermatosis, eosinophilia, leukocytoclastic vasculitis, leukocytosis, purpura, pyrexia, rash erythematous, rash maculo-papular. Josir dosage: . During the same period patient was treated with PROSCAR (5 Mg) (View Proscar Review and Proscar Label ), PREVISCAN (View Previscan Review and Previscan Label ), CORDARONE (View Cordarone Review and Cordarone Label ), MONOTILDIEM (View Monotildiem Review and Monotildiem Label ). Patient was hospitalized.

6022152-2 | Abortion Spontaneous, Genital Haemorrhage, Multiple Pregnancy
Patient was taking Josir (View Usage). Patient had the following side effects: abortion spontaneous, genital haemorrhage, multiple pregnancy on Dec 18, 2008 from Additional patient health information: Female patient , 35 years of age, was diagnosed with pollakiuria and. Josir dosage: .4mg.

5703360-4 | Eosinophilia, Leukocytosis, Purpura, Pyrexia, Rash Maculo-papular, Renal Impairment
Adverse event was reported on Apr 02, 2008 by a Male patient taking Josir (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia and. Location: FRANCE , 80 years of age, After Josir was administered, patient had the following side effects: eosinophilia, leukocytosis, purpura, pyrexia, rash maculo-papular, renal impairment. During the same period patient was treated with PROSCAR (View Proscar Review and Proscar Label ), PREVISCAN (View Previscan Review and Previscan Label ), CORDARONE (View Cordarone Review and Cordarone Label ), MONOTILDIEM (View Monotildiem Review and Monotildiem Label ). Patient was hospitalized.

5600550-6 | Erythema, Prurigo, Pruritus
on Jan 11, 2008 Male patient from FRANCE , 83 years of age, was treated with Josir (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, prurigo, pruritus. Josir dosage: . During the same period patient was treated with VERCYTE (View Vercyte Review and Vercyte Label ), INEXIUM (View Inexium Review and Inexium Label ), FORLAX (View Forlax Review and Forlax Label ), CORDARONE (View Cordarone Review and Cordarone Label ). Patient was hospitalized.


5279393-1 | Hyponatraemia, Malaise
on Mar 26, 2007 Male patient from FRANCE , 72 years of age, was treated with Josir (View Usage). Patient had the following side effects: hyponatraemia, malaise. Josir dosage: . Patient was hospitalized.

5246923-5 | Anaemia, Condition Aggravated, Neutropenia
Patient was taking Josir (View Usage). After Josir was administered, patient had the following side effects: anaemia, condition aggravated, neutropenia on Feb 19, 2007 from FRANCE Additional patient health information: Male patient , 76 years of age, . Josir dosage: . During the same period patient was treated with HYDREA (View Hydrea Review and Hydrea Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), KARDEGIC (View Kardegic Review and Kardegic Label ), SECTRAL (View Sectral Review and Sectral Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

5236286-3 | Anaemia, Condition Aggravated, Neutropenia
Adverse event was reported on Feb 06, 2007 by a Male patient taking Josir (View Usage) (Dosage: ) . Location: FRANCE , 76 years of age, Patient experienced the following unwanted or unexpected effects: anaemia, condition aggravated, neutropenia. During the same period patient was treated with HYDREA (View Hydrea Review and Hydrea Label ), LIPANTHYL (View Lipanthyl Review and Lipanthyl Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), SEDRAL (View Sedral Review and Sedral Label ), PREVISCAN (View Previscan Review and Previscan Label ). Patient was hospitalized.

5196230-4 | Hyperhidrosis, Pain, Respiratory Distress, Vertigo
on Dec 28, 2006 Male patient from ALGERIA , weighting 187.4 lb, was treated with Josir (View Usage). Patient had the following side effects: hyperhidrosis, pain (What is pain?), respiratory distress, vertigo. Josir dosage: .

5160484-0 | Shock
on Nov 23, 2006 Male patient from FRANCE , 83 years of age, weighting 123.5 lb, was treated with Josir (View Usage). After Josir was administered, patient had the following side effects: shock. Josir dosage: . During the same period patient was treated with ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), EQUANIL (View Equanil Review and Equanil Label ), TERCIAN (View Tercian Review and Tercian Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), DEPAKENE (View Depakene Review and Depakene Label ).

5125250-0 | Cough, Dyspnoea, Rhinitis
Patient was taking Josir (View Usage). Patient experienced the following unwanted or unexpected effects: cough, dyspnoea, rhinitis on Oct 03, 2006 from FRANCE Additional patient health information: Male patient , weighting 165.3 lb, was diagnosed with benign prostatic hyperplasia and. Josir dosage: .

5119866-5 | Anaemia, Thrombocytopenic Purpura
Adverse event was reported on Sep 25, 2006 by a Male patient taking Josir (View Usage) (Dosage: ) . Location: FRANCE , 94 years of age, Patient had the following side effects: anaemia, thrombocytopenic purpura. During the same period patient was treated with LOXEN (View Loxen Review and Loxen Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), LASIX (View Lasix Review and Lasix Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

5104091-4 | Dehydration, Heat Stroke, Hyperthermia, Hypotension, Malaise, Renal Failure
on Sep 05, 2006 Male patient from FRANCE , 70 years of age, was treated with Josir (View Usage). After Josir was administered, patient had the following side effects: dehydration, heat stroke, hyperthermia, hypotension, malaise, renal failure. Josir dosage: . During the same period patient was treated with LERCAN (View Lercan Review and Lercan Label ), LARGACTIL (View Largactil Review and Largactil Label ), PARLODEL (View Parlodel Review and Parlodel Label ), LASILIX (View Lasilix Review and Lasilix Label ), TRANSIPEG (View Transipeg Review and Transipeg Label ), DEPAMIDE (View Depamide Review and Depamide Label ), MEPRONIZINE (View Mepronizine Review and Mepronizine Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ). Patient was hospitalized.

4969660-0 | Biliary Cyst, Helicobacter Gastritis, Hiccups, Nephrocalcinosis, Renal Cyst, Respiratory Disorder
on Jan 27, 2006 Male patient from FRANCE , 80 years of age, was diagnosed with benign prostatic hyperplasia and was treated with Josir (View Usage). Patient experienced the following unwanted or unexpected effects: biliary cyst, helicobacter gastritis, hiccups, nephrocalcinosis, renal cyst, respiratory disorder. Josir dosage: . During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), VASTAREL (View Vastarel Review and Vastarel Label ), BUSPIRONE (View Buspirone Review and Buspirone Label ), CATACOL (View Catacol Review and Catacol Label ), TINSET (View Tinset Review and Tinset Label ). Patient was hospitalized.

4909010-9 | Nephrolithiasis, Urinary Retention
Patient was taking Josir (View Usage). Patient had the following side effects: nephrolithiasis, urinary retention on Oct 24, 2005 from FRANCE Additional patient health information: Male patient , 75 years of age, . Josir dosage: . Patient was hospitalized.

4900054-X | Hiccups
Adverse event was reported on Jan 27, 2006 by a Male patient taking Josir (View Usage) (Dosage: ) was diagnosed with benign prostatic hyperplasia and. Location: FRANCE , 80 years of age, After Josir was administered, patient had the following side effects: hiccups. During the same period patient was treated with ATACAND (View Atacand Review and Atacand Label ), BUFLOMEDIL (View Buflomedil Review and Buflomedil Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), VASTAREL (View Vastarel Review and Vastarel Label ), BUSPIRONE (View Buspirone Review and Buspirone Label ), CATACOL (View Catacol Review and Catacol Label ), TINSET (View Tinset Review and Tinset Label ). Patient was hospitalized.

4872563-3 | Arthralgia, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Hepatic Steatosis, Interstitial Lung Disease, Myalgia, Prostatitis, Pyrexia, Rash Maculo-papular
on May 19, 2005 Male patient from FRANCE , 64 years of age, weighting 180.8 lb, was diagnosed with prostatitis and was treated with Josir (View Usage). Patient experienced the following unwanted or unexpected effects: arthralgia, aspartate aminotransferase increased, blood creatine phosphokinase increased, hepatic steatosis, interstitial lung disease, myalgia, prostatitis, pyrexia, rash maculo-papular. Josir dosage: . During the same period patient was treated with NOROXIN (View Noroxin Review and Noroxin Label ), BEFIZAL (View Befizal Review and Befizal Label ), DI ANTALVIC (6 Ta Daily) (View Di-antalvic Review and Di-antalvic Label ), TAVANIC (View Tavanic Review and Tavanic Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

4843065-5 | Hyponatraemia
on Nov 02, 2005 Male patient from , 85 years of age, was treated with Josir (View Usage). Patient had the following side effects: hyponatraemia. Josir dosage: . During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ), AERIUS (View Aerius Review and Aerius Label ), SEROPLEX (View Seroplex Review and Seroplex Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), COVERSYL (View Coversyl Review and Coversyl Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

4827942-7 | Hyponatraemia
Patient was taking Josir (View Usage). After Josir was administered, patient had the following side effects: hyponatraemia on Nov 02, 2005 from Additional patient health information: Male patient , 85 years of age, . Josir dosage: . During the same period patient was treated with DOMPERIDONE (View Domperidone Review and Domperidone Label ), AERIUS (View Aerius Review and Aerius Label ), SEROPLEX (View Seroplex Review and Seroplex Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), COVERSYL (View Coversyl Review and Coversyl Label ), ZOPICLONE (View Zopiclone Review and Zopiclone Label ). Patient was hospitalized.

4818885-3 | Nephrolithiasis, Prostatic Disorder, Urinary Retention
Adverse event was reported on Oct 24, 2005 by a Male patient taking Josir (View Usage) (Dosage: ) . Location: FRANCE , 75 years of age, Patient experienced the following unwanted or unexpected effects: nephrolithiasis, prostatic disorder, urinary retention. Patient was hospitalized.

4766914-8 | Angioneurotic Oedema, Brain Oedema
on Aug 18, 2005 Male patient from , 85 years of age, was diagnosed with benign prostatic hyperplasia, hypercholesterolaemia, gastroduodenal ulcer, prostate cancer metastatic, ischaemic stroke, pulmonary embolism (What is pulmonary embolism?) and was treated with Josir (View Usage). Patient had the following side effects: angioneurotic oedema, brain oedema. Josir dosage: . During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), DEROXAT (View Deroxat Review and Deroxat Label ), NEXIUM (View Nexium Review and Nexium Label ), CASODEX (View Casodex Review and Casodex Label ), PREVISCAN (View Previscan Review and Previscan Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

4755472-X | Angioneurotic Oedema, Bronchospasm, Convulsion, Cyanosis, Dyspnoea, Hypocomplementaemia, Respiratory Arrest
on Aug 18, 2005 Male patient from , 85 years of age, was diagnosed with benign prostatic hyperplasia, hypercholesterolaemia, gastroduodenal ulcer, prostate cancer metastatic, ischaemic stroke, pulmonary embolism (What is pulmonary embolism?) and was treated with Josir (View Usage). After Josir was administered, patient had the following side effects: angioneurotic oedema, bronchospasm, convulsion, cyanosis, dyspnoea, hypocomplementaemia, respiratory arrest. Josir dosage: . During the same period patient was treated with CORDARONE (View Cordarone Review and Cordarone Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), PAROXETINE HCL (View Paroxetine Hcl Review and Paroxetine Hcl Label ), NEXIUM (View Nexium Review and Nexium Label ), CASODEX (View Casodex Review and Casodex Label ), PREVISCAN (View Previscan Review and Previscan Label ), TARDYFERON (View Tardyferon Review and Tardyferon Label ). Patient was hospitalized.

4713996-5 | Condition Aggravated, Crohn's Disease
Patient was taking Josir (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, crohn's disease (What is crohn's disease?) on Jul 04, 2005 from FRANCE Additional patient health information: Male patient , 67 years of age, was diagnosed with prostatic adenoma and. Josir dosage: . During the same period patient was treated with SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), DIPENTUM (View Dipentum Review and Dipentum Label ). Patient was hospitalized.

4680731-9 | Arthralgia, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Diarrhoea, Hepatic Steatosis, Joint Effusion, Lichenoid Keratosis, Lung Disorder, Myalgia
Adverse event was reported on May 19, 2005 by a Male patient taking Josir (View Usage) (Dosage: ) was diagnosed with prostatitis and. Location: , 64 years of age, weighting 180.8 lb, Patient had the following side effects: arthralgia, aspartate aminotransferase increased, blood creatine phosphokinase increased, diarrhoea, hepatic steatosis, joint effusion, lichenoid keratosis, lung disorder, myalgia. During the same period patient was treated with NOROXIN (View Noroxin Review and Noroxin Label ), BEFIZAL (View Befizal Review and Befizal Label ), DI ANTALVIC (6 Ta Daily) (View Di-antalvic Review and Di-antalvic Label ), TAVANIC (View Tavanic Review and Tavanic Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

4660033-7 | Leukopenia, Neutropenia
on Apr 29, 2005 Female patient from , 27 years of age, was treated with Josir (View Usage). After Josir was administered, patient had the following side effects: leukopenia, neutropenia. Josir dosage: . During the same period patient was treated with KEPPRA (Two Ta Daily) (View Keppra Review and Keppra Label ), XANAX (View Xanax Review and Xanax Label ), LOVENOX (View Lovenox Review and Lovenox Label ), MICROPAKINE (View Micropakine Review and Micropakine Label ), FUMAFER (View Fumafer Review and Fumafer Label ). Patient was hospitalized.

4637589-3 | Retinal Vein Occlusion, Visual Acuity Reduced
on Feb 04, 2005 Male patient from , weighting 163.1 lb, was treated with Josir (View Usage). Patient experienced the following unwanted or unexpected effects: retinal vein occlusion, visual acuity reduced. Josir dosage: .

4635192-2 | Blood Creatinine Increased, Blood Pressure Fluctuation, Ecchymosis, Fall, Head Injury, Heart Rate Decreased, Loss Of Consciousness, Malaise, Orthostatic Hypotension
Patient was taking Josir (View Usage). Patient had the following side effects: blood creatinine increased, blood pressure fluctuation, ecchymosis, fall (What is fall?), head injury, heart rate decreased, loss of consciousness, malaise, orthostatic hypotension on Mar 29, 2005 from Additional patient health information: Male patient , 85 years of age, weighting 154.3 lb, was diagnosed with prostatic adenoma, hypertension and. Josir dosage: . During the same period patient was treated with ESIDRIX (View Esidrix Review and Esidrix Label ), SECTRAL (View Sectral Review and Sectral Label ), TRIATEC (View Triatec Review and Triatec Label ), AMLOR (View Amlor Review and Amlor Label ), HYPERIUM (View Hyperium Review and Hyperium Label ), PLAVIX (View Plavix Review and Plavix Label ), BETASERC (View Betaserc Review and Betaserc Label ), ACTONEL (View Actonel Review and Actonel Label ). Patient was hospitalized.